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↑ What is "already known" in this topic: {#box1}
========================================

Except for the intermediate tumors, the frozen section method has shown great accuracy in dealing with pelvic masses.

→ What this article adds: {#box2}
=========================

Higher precision in isolating specimens for frozen sections, especially in large masses, and cooperation of the surgeon and pathologist can enhance the value of this method. In addition, except for CA125, this method can prevent performing tumor marker tests, which are costly and are of low diagnostic value.

Introduction {#s1}
============

Pelvic masses comprise a large portion of female surgeries. The origin and cause of these masses could be from the gynecological, urinary, or digestive systems ([@R1]). The most prevalent pelvic mass for all age groups was related to the ovaries. Pelvic masses are important in the early diagnosis of malignant tumors of the ovaries ([@R2]). Ovarian cancer is the deadliest gynecological malignancy, the seventh malignant cancer, and the seventh prevalent cause of death due to cancer among females worldwide because the associated mortality is greater than the combined mortalities secondary to the cervix and endometrial cancers ([@R3]). Different kinds of benign and malignant pelvic masses with different percentages appear in various age groups; therefore, early diagnosis and choosing the correct method of surgery for these kinds of masses is of high importance ([@R1]).

Early diagnosis methods for pelvic masses comprise physical examinations, ultrasonography, computed tomography (CT) scans, magnetic resonance imaging scan (MRIs), tumor markers, and microscopic and frozen section diagnoses during surgery. Definite and final diagnoses are also recorded based on permanent histological specimens ([@R4]-[@R6]). In gynecological and obstetrical diseases, providing frozen sections has been the most helpful method in determining the type and method of treatment of suspicious pelvic masses ([@R7]). Many studies have been performed to determine the value of diagnostic precision of frozen section for masses of different body organs; however, each provided relatively different results depending on the organ and tissue under study. Taskiran et al (2008) concluded that frozen section has a high sensitivity and specificity in the diagnosis of adnexal masses ([@R8]).

Wootipoon et al (2006), after studying 229 ovarian specimens, found that frozen section seems to be a useful method for the diagnosis of ovarian masses ([@R9]). The present study measures the compatibility of the frozen section method in histological specimens of female pelvic masses with the results of pathology and tumor markers.

Methods {#s2}
=======

This retrospective study was performed on 188 specimens of female pelvic masses. Samples were collected from women\'s ward of Beesat hospital in Sanandaj, Iran, during 2014-2016. First, file numbers for patients with pelvic masses who had undergone surgery by gynecology and obstetrics specialists were extracted. Then, a designed questionnaire was filled out based on patient data, results of pathology testing, results of tumor markers, and results of frozen section. After the data collection, SPSS version 19 was used to describe the frequency and means. The results were analyzed using Kappa test and important indices were calculated using the following formula: sensitivity: a/(a+c), specificity: d/(b+d), positive predictive value: a/(a+b), and negative predictive value: d/(c+d) ([Table 1](#T1){ref-type="table"}).

###### Cross table for calculation of diagnostic test

  --------------------------- --------------------- ---
  Results of frozen section   Result of pathology   
  \+                          \-                    
  \+                          a                     b
  \-                          c                     d
  --------------------------- --------------------- ---

Results {#s4}
=======

In this study, the mean age for the group with non-neoplastic masses was 41.8±13 and was 57.2±12.9 for the group with neoplastic masses. Among 188 patients, based on the final pathology, 150 (79.8%) cases were benign, 8 (4.2%) intermediate, and 30 (16%) malignant. The most prevalent benign ovarian tumor was Serous Cystadenoma (32 cases, 17%), followed by Dermoid Cyst (19 cases, 10%), Mucinous Cystadenoma (18 cases, 9.5%), Endometriotic Cyst (16 cases, 8.5%), physiologic cysts, including follicular and corpus luteum cysts (15 cases, 8%), and sex cord-stromal tumors (11 cases, 8.5%). Among the intermediate specimens, 7 cases were Serous and one was Mucinous ([Table 2](#T2){ref-type="table"}).

###### The frequency of different pelvic masses based on reports of frozen section method and final pathology

  -------------------------- ------------------ ----------------------------- ----------- -----------
  Origin of Mass             Pelvic Masses      Frequency                                 
  Frozen section             Final pathology                                              
  Ovary                      Germ cell          Dermoid cyst                  19(10.1%)   19(10.1%)
  Fibroma                    1(0.5%)            1(0.5%)                                   
  Sex cord-stromal           Fibrothecoma       6(3.2%)                       5(2.7%)     
  Thecoma                    0(0%)              10.5%)                                    
  Granulosa cell tumor       42.1%)             4(2.1%)                                   
  Endometriotic cyst         16(8.5%)           16(8.5%)                                  
  Serous cystadenoma         31(16.5%)          32(17%)                                   
  Mucinous cystadenoma       18(9.6%)           18(9.6%)                                  
  Serous tumor               7(3.7%)            6(3.2%)                                   
  Mucinous tumor             0(0%)              0(0%)                                     
  Endometroid tumor          2(1.1%)            2(1.1%)                                   
  Epithelial                 Physiologic cyst   19(10.1%)                     15(8%)      
  Borderline tumor           7(3.7%)            8(4.3%)                                   
  Papillary cell carcinoma   1(0.5%)            1(0.5%)                                   
  Metastatic tumor                              2(1.1%)                       3(1.6%)     
  Adenocarcinoma             10(5.3%)           10(5.3%)                                  
  Endometrial polyp          1(0.5%)            1(0.5%)                                   
  Leiomyosarcoma             2(1.1%)            2(1.1%)                                   
  Uter-us                    Uterine            Endometrial stromal sarcoma   0(0%)       0(0%)
  Leiomyoma                  39(20.7%)          40(21.3%)                                 
  Adenomyosis                3(1.6%)            3(1.6%)                                   
  Endometriosis              0(0%)              1(0.5%)                                   
  Total                                                                       188(100%)   188(100%)
  -------------------------- ------------------ ----------------------------- ----------- -----------

Serous Carcinoma was the most prevalent malignant ovarian neoplasm (6 cases, 3.2%), followed by Granulosa cell tumors (4 cases, 2.1%). The most common benign uterine legions were Leiomyoma (40 cases, 21.3%), followed by Uterine Adenomyosis (3 cases, 1.6%). Also, the most prevalent malignant uterine masses were Adenocarcinoma (10 cases, 5.3%), followed by Uterine Leiomyosarcoma (2 cases, 1.1%) ([Table 2](#T2){ref-type="table"}). The sensitivity, specificity, and validity of frozen section in benign tumors ([Table 3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}) were calculated as follow: 96.7 (CI~95%~: 92.6--98.9%), 97 (CI~95%~:84.7--99.9%), and 96.8%. The sensitivity, specificity, and validity of frozen section in intermediate tumors were 71.4 (CI~95%~: 29--96.3%), 98.3 (CI~95%~: 95.2--99.7%), 97.3%; and in malignant tumors: 96.3 (CI~95%~: CI~95%~: 81.9--99%), 97.4 (CI~95%~: 93.4--99.3%), and 97.2%. Positive and negative predictive values were calculated as follow: 99.3 (CI~95%~: 96.3--99.9%) and 86.8% (CI~95%~: 71.9--95.6%) in benign tumors; 62.5 (CI~95%~: 24.5--91.5%) and 98.9% (CI~95%~: 96--99.9%) in intermediate tumors; and 86.7 (CI~95%~: 69. 3--96.2%) and 99.3% (CI~95%~: 96.3--99.9%) in malignant tumors. The results of this study showed that frozen section method has sensitivity of 96.3% (CI~95%~: 81-9.9%), specificity of 97.5% (CI~95%~: 93.8-99.3%), positive predictive value of 86.7% (CI~95%~: 69.3-96.2%), negative predictive value of 99.4% (CI~95%~: 96.5-99.9%), accuracy of 97.3%, and Kappa of 0.868 ([Table 5](#T5){ref-type="table"}).

###### Agreement between the results of pathology test and reports of frozen section

  ------------------------------------------------------------------------ ----------- ---------
  Compatibility between the report of frozen section and final pathology   Frequency   Percent
  Compatibility (both positive and both negative)                          175         93.1
  Not compatibility                                                        13          6.9
  Total                                                                    188         100.0
  ------------------------------------------------------------------------ ----------- ---------

###### Comparison of frozen section and final pathology in the diagnosis of different kinds of pelvic masses

  ------------------- ----------------- ---------------- ------------- ------------
  Results of Frozen   Final Pathology   Total                          
  Section             Neoplastic        Non neoplastic   Border line   
  Neoplastic          26(13.8%)         0(0%)            1(0.5%)       27(14.4%)
  Non neoplastic      3(1.6%)           149(79.3%)       2(1.1%)       154(81.9%)
  Borderline          1(0.5%)           1(0.5%)          5(2.7%)       7(3.7%)
  Total               30(16%)           150(79.8%)       8(4.2%)       188(100%)
  ------------------- ----------------- ---------------- ------------- ------------

###### Estimations of sensitivity, specificity, positive and negative predictive values, false positive and negative cases, and validity of frozen section in the diagnosis of pelvic masses

  --------------------------- -------------------- -------------------- --------------------
  Frozen Section              Benign\              Borderline\          Malignant\
                              Percent (CI~95%~)    Percent (CI~95%~)    Percent (CI~95%~)

  Sensitivity                 99.3% (96.3-99.9%)   62.5% (24.5-91.5%)   86.7% (69.3-96.2%)

  Specificity                 86.8% (71.9-95.6%)   98.9% (96-99.9%)     99.4% (96.5-99.9%)

  Positive predictive value   96.7% (92.6-98.9%)   71.4% (29-96.3%)     96.3% (81-99.9%)

  Negative predictive value   97% (84.7-99.9%)     98.3% (95.2-99.7%)   97.5% (93.8-99.3%)

  False positive              13.2% (4.4-28.1)     1.1% (0.13-3.9)      0.63% (0.02-3.5%)

  False negative              0.67% (0.02-3.7%)    37.5% (8.5-75.5%)    13.3% (3.7-30.7%)

  Accuracy                    96.8% (93.2-98.8%)   97.3% (93.9-99.1%)   97.3% (93.9-99.1%)

  Kappa                       89.7 (81.6-97.8)     65.3 (36.9-93.7)     89.7 (80.7-98.6)
  --------------------------- -------------------- -------------------- --------------------

CI~95%~: 95% Confidence interval

The significant association of positive tumor markers with reports of final pathology was seen in CA125 (p\<0.001‏( ([Table 6](#T6){ref-type="table"}).

###### The association of positive tumor markers with reports of final pathology

  ----------------------- --------------------------- ------------ ----------
  Positive Tumor marker   Report of final pathology   p            
                          Not Neoplastic              Neoplastic   
  LDH                     11(7%)                      5(16.7%)     0.081
  CA125                   21(13.3%)                   12(40%)      \< 0.001
  CEA                     3(1.9%)                     3(10%)       0.053
  AFP                     8 (5.1%)                    1 (3.3%)     1
  BHCG                    2 (1.3%)                    0 (0%)       1
  ----------------------- --------------------------- ------------ ----------

Discussion {#s5}
==========

In gynecological and obstetrical diseases, providing frozen sections has been the most helpful method in determining the type and method of treatment of suspicious pelvic masses ([@R7]). Many studies have been performed to determine the value of diagnostic precision for frozen sections in masses of different body organs; however, each have provided relatively different results depending on the organ and tissue under study. Ilvas et al (2005), in a retrospective study on 1494 ovarian specimens, out of which 617 had gone under frozen section during 1995--2003, calculated the total value of frozen section to be 97% That 21 cases were incorrectly diagnosed by frozen section The primary reason for these errors was determined to be Mucinous and Borderline tumors. Finally, they reached the conclusion that frozen section is a reliable method in the diagnosis of ovarian masses ([@R10]). Allameh et al (2005) studied 45 tissue samples from patients during ovarian mass surgery and found that the sensitivity and specificity of diagnosis by frozen section in malignant ovarian masses were 100% and 88.5%, respectively; however, for benign masses, they were 88.5% and 77%, respectively. Finally, they concluded that frozen section is a reliable method for diagnosing the type of histology and ovarian masses ([@R11]). Taskiran et al (2008) conducted a study on 207 patients, which according to preliminary calculations that considered borderline histology as malignant, the diagnostic sensitivity and specificity of frozen section was 97% and 92%, respectively. In the secondary analysis, in which borderline cases were considered benign, diagnostic sensitivity and specificity of this method was 100% and 98%, respectively. They concluded that frozen section have high sensitivity and specificity; however, other diagnostic markers are required to enhance the diagnostic value, especially in patients with large lesions, borderline tumors, and Mucinous ([@R8]). Also, Maghami et al (2010) studied 31 patients with a preliminary diagnosis of endometrial carcinoma to compare the value of diagnostic accuracy of the frozen section with final reports of their pathology. It was found that pathologic invasion to myometrium was correctly reported for 90% of patients. Finally, frozen sections were considered valuable in the detection of the early stages of low-grade tumors ([@R12]). Ah et al (2016) performed a retrospective study at Shafa International Hospital to determine the value of frozen section during surgery in the detection of different pelvic neoplasms, including ovarian tumors. The mentioned study was performed on all the patients with injury to the female genital system who had undergone frozen section surgery between January 2010 and December 2012. They concluded that frozen section had considerable value in dealing with pelvic masses with suspicious malignancy ([@R13]). Other studies have also pointed out the role of frozen sections in dealing with pelvic masses ([@R14]-[@R18]).

In the present study, out of 188 studied patients, there were 4 errors in the detection of benignity, malignancy, or borderline regarding the masses. Moreover, 2 of these cases were related to borderline tumors and the other 2 were mistakably reported as benign instead of malignant due to inadequate frozen section specimens. Because of a conservative treatment approach in these 2 cases, no errors were made. In 175 cases (93.1%), the type of reported mass was completely compatible with frozen sections and final pathology, but they were incompatible in 13 cases (6.9%),. The most prevalent reason for incompatibility in the 4 cases was related to borderline tumors. In another 4 cases, the inadequacy of frozen section specimens and in 2 cases, incompatibility was related to Granulosa cell tumors. Contrary to other similar studies that had pointed out Mucinous tumors as a reason for error, in this study, there were only 2 erroneous cases when distinguishing between benign Mucinous cysts and Serous. Studying the results of tumor marker tests also showed that among CEA, CA125, BHCG, and LDH, there was a significant relationship only between CA125 and the report of final pathology. Therefore, to reduce the costs of the treatment for patients, only the CA125 tumor marker can be evaluated.

Conclusion {#s6}
==========

The results of this study showed that frozen section method has managed to keep its value and place among all diagnostic methods regarding pelvic masses to an acceptable extent. Higher precision in isolating specimens for frozen sections, especially in large masses, and cooperation of the surgeon and pathologist can enhance the value of this method. In addition, except for CA125, this method can prevent performing tumor marker tests, which are costly and are of low diagnostic value.
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